Ovarian-derived hydrogels for biomedical and biotechnology applications
US12064532B2 · kind B2 · utility
0Cited by
3References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 2022 |
| Grant date | Aug 20, 2024 |
| Priority date | — |
| Expiry date | Jul 25, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2533/90
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The present invention relates to an ovarian-derived hydrogel material, which can be useful for three-dimensional in vitro culturing of cells, cell therapy, fertility preservation, drug delivery, site-specific remodeling and repair of damaged tissue, and/or diagnostic kits.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.